These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H. J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302 [Abstract] [Full Text] [Related]
5. Effect of castration and finasteride on urinary oxalate excretion in male rats. Fan J, Glass MA, Chandhoke PS. Urol Res; 1998 Sep; 26(1):71-5. PubMed ID: 9537700 [Abstract] [Full Text] [Related]
7. A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats. Tsai CH, Chen YC, Chen LD, Pan TC, Ho CY, Lai MT, Tsai FJ, Chen WC. Urol Res; 2008 Feb; 36(1):17-24. PubMed ID: 18040675 [Abstract] [Full Text] [Related]
8. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Khan SR, Hackett RL. Scan Electron Microsc; 1985 Feb; (Pt 2):759-74. PubMed ID: 3901237 [Abstract] [Full Text] [Related]
13. The role of long-term loading of cholesterol in renal crystal formation. Itoh Y, Yoshimura M, Niimi K, Usami M, Hamamoto S, Kobayashi T, Hirose M, Okada A, Yasui T, Tozawa K, Kohri K. Arch Ital Urol Androl; 2011 Mar; 83(1):23-5. PubMed ID: 21585165 [Abstract] [Full Text] [Related]
14. A comparative study on several models of experimental renal calcium oxalate stones formation in rats. Liu J, Cao Z, Zhang Z, Zhou S, Ye Z. J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118 [Abstract] [Full Text] [Related]
15. Effect of sex hormones on crystal formation in a stone-forming rat model. Yoshioka I, Tsujihata M, Momohara C, Akanae W, Nonomura N, Okuyama A. Urology; 2010 Apr; 75(4):907-13. PubMed ID: 20163845 [Abstract] [Full Text] [Related]
16. Effect of magnesium on calcium oxalate urolithiasis. Su CJ, Shevock PN, Khan SR, Hackett RL. J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799 [Abstract] [Full Text] [Related]
17. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. Marengo SR, Chen DH, Kaung HL, Resnick MI, Yang L. J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477 [Abstract] [Full Text] [Related]
18. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation. de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van 't Noordende JM, Schrder FH. Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010 [Abstract] [Full Text] [Related]
19. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. de Water R, Boevé ER, van Miert PP, Deng G, Cao LC, Stijnen T, de Bruijn WC, Schröder FH. Scanning Microsc; 1996 Mar; 10(2):591-601; discussion 601-3. PubMed ID: 9813634 [Abstract] [Full Text] [Related]
20. Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model. Zhu W, Xu YF, Feng Y, Peng B, Che JP, Liu M, Zheng JH. Urolithiasis; 2014 Dec; 42(6):519-26. PubMed ID: 25085199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]